THỰC TRẠNG KIỂM SOÁT YẾU TỐ NGUY CƠ TIM MẠCH Ở NGƯỜI BỆNH TĂNG HUYẾT ÁP ĐIỀU TRỊ NGOẠI TRÚ TẠI BỆNH VIỆN ĐA KHOA BA VÌ NĂM 2025

Abstract

Background: Hypertension (HTN) is a major cardiovascular risk factor. Controlling blood pressure (BP) and associated risk factors—including diabetes, dyslipidemia, and obesity—is essential to reducing cardiovascular events. Ba Vi General Hospital manages a large number of hypertensive outpatients; however, no study has been conducted to evaluate the current status of cardiovascular risk factor control at this facility. Objectives: (1) To assess the status of cardiovascular risk factor control among hypertensive outpatients at Ba Vi General Hospital in 2025; (2) To identify factors associated with blood pressure control.Subjects and Methods: A cross-sectional descriptive study was conducted on 400 hypertensive outpatients managed at the Hypertension Clinic of Ba Vi General Hospital in 2025. Clinical data, blood pressure, fasting glucose, HbA1c, LDL-C, BMI, medical history, and antihypertensive therapy were collected. Data were processed using Epidata and SPSS.Key Findings: A total of 400 patients were included: 200 males (50%) and 200 females (50%). Patients aged ≥55 years accounted for 88.5%. Those with lower secondary education or below accounted for 58.5%.Blood pressure control: 32.5% achieved target BP (130/400), while 67.5% did not.Glycemic control: HbA1c at target in 25%; fasting glucose at target in 39.7%.LDL-C control: 44.2% achieved target.Statistical associations: Achievement of BP, glucose, and LDL-C targets differed significantly by age group, education level, and BMI category (p < 0.05 in multiple comparisons). Overweight/obese patients had markedly lower control rates (p < 0.001). Patients with higher education levels achieved LDL-C goals more frequently (p = 0.004). Conclusions: Rates of BP and cardiovascular risk factor control among the study population were low (BP control 32.5%; LDL-C 44.2%; HbA1c 25%). Age, BMI, and educational level were associated factors. Continuous interventions at the primary care level are needed, including enhanced lifestyle counseling, optimization of pharmacologic therapy, and strengthened outpatient management.